Callan JMB Partners With Alabama State University To Support Development Of Integrated Pharmaceutical Manufacturing Ecosystem To Strengthen Domestic Pharmaceutical Production And Supply Chain Resilience.

Saved in:
Bibliographic Details
Title: Callan JMB Partners With Alabama State University To Support Development Of Integrated Pharmaceutical Manufacturing Ecosystem To Strengthen Domestic Pharmaceutical Production And Supply Chain Resilience.
Authors: Benzinga Newsdesk
Source: Benzinga. 07/16/2026.
Abstract: Management believes the initiative could represent a potential $414 million five-year revenue opportunity for Callan JMB while helping establish a next-generation pharmaceutical manufacturing ecosystem in the United States. MARION, Ala., July 16, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced a strategic partnership with Alabama State University (ASU) to support the development of an integrated pharmaceutical manufacturing ecosystem designed to strengthen domestic pharmaceutical production, enhance supply chain resilience, advance workforce development, and improve national medical preparedness. [ABSTRACT FROM PUBLISHER]
Database: Newspaper Source Plus
Full text is not displayed to guests.
Description
Abstract:Management believes the initiative could represent a potential $414 million five-year revenue opportunity for Callan JMB while helping establish a next-generation pharmaceutical manufacturing ecosystem in the United States. MARION, Ala., July 16, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced a strategic partnership with Alabama State University (ASU) to support the development of an integrated pharmaceutical manufacturing ecosystem designed to strengthen domestic pharmaceutical production, enhance supply chain resilience, advance workforce development, and improve national medical preparedness. [ABSTRACT FROM PUBLISHER]